Clinical Trial Update: ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating an ATG-based conditioning regimen for HLA-related hematopoietic stem cell transplantation in aggressive T-cell tumors, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoblastic Lymphoma

Drugs mentioned

• Antithymocyte Globulin (ATG) (antithymocyte globulin)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Lymphoblastic Lymphoma | Phase 4 | Status: UNKNOWN